Embracing innovative designs in early phase oncology trials
White Paper
Feb 01, 2019
A Different Route to Faster Approvals

Advancements in science and technology combined with unmet patient needs are driving accelerated timelines and creative pathways for oncology drug development. 

Download this white paper to explore seamless clinical trial strategies and protocol design considerations to help you choose the best way forward for your oncology clinical trial. 

You will learn:
Considerations for protocol design to help ensure the best way forward
Understand how seamless oncology clinical trial strategy differs from traditional pathways 
Explore novel trial design options for early phase oncology studies to potentially accelerate approval timelines
How oncology sponsors and regulators alike are embracing a streamlined path that bypasses the traditional development paradigm of standalone sequential Phase I, II and III trials.

Having an experienced team with oncology expertise is critical to the success of your clinical development program. Contact us to learn how our dedicated oncology team can support your clinical trial.
 
You may also be interested in
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Contact Us